Introduction to Wegovy:
Wegovy has taken the country by storm and has quickly become one of the leading medications for weight loss in the UK. Wegovy is a UK-licensed pharmaceutical used to support significant and sustainable weight loss. This advanced prescription medication is specifically designed to help individuals reduce excess weight and maintain a healthy body composition. Clinical trials have demonstrated that, on average, adults using Wegovy achieve a weight loss of approximately 15% of their initial body weight, which equates to about 35 pounds. Wegovy has quickly gained recognition and become one of the leading weight loss medications in the UK.
Licenses and Approvals:
Wegovy is one of the few medications granted a specific license for weight loss in the United Kingdom, distinguishing it from medications like Ozempic, which is primarily approved for the management of diabetes. Wegovy's UK licensing for weight loss highlights its efficacy in assisting individuals with their weight loss goals. In contrast, Ozempic, while globally approved for diabetes management, is primarily intended to improve glycaemic control. Wegovy's specialized license underscores its role as a dedicated and effective weight management solution, further supporting individuals in their journey toward improved health.
Benefits for Wegovy:
Wegovy offers several key benefits for individuals seeking to achieve and maintain weight loss:
Expected Weight Loss: Clinical studies show that Wegovy helps individuals lose approximately 15% of their initial body weight, with one in three adults losing up to 46 pounds. This makes Wegovy an excellent option for those aiming to reduce weight and improve their overall health.
Appetite Control: Wegovy targets appetite-regulating centres in the brain, reducing cravings and helping to prevent overeating, which can contribute to sustainable weight loss.
Precautions:
Always consult with your healthcare provider before starting Wegovy to determine if it is the appropriate option for you and to discuss any potential risks or interactions with other medications.
Most individuals taking Wegovy experience mild side effects. The most common side effects include nausea, diarrhoea, vomiting, constipation, abdominal pain, headache, fatigue, upset stomach, dizziness, bloating, belching, gas, stomach flu, heartburn, and a runny nose or sore throat.
Wegovy may also cause serious side effects, including:
Pancreatitis (inflammation of the pancreas): If you experience severe, persistent abdominal pain, with or without vomiting, contact your healthcare provider immediately. The pain may radiate from the abdomen to the back.
Gallbladder problems: Wegovy may lead to gallbladder issues, including gallstones, some of which may require surgery. Contact your healthcare provider if you develop symptoms such as upper abdominal pain, fever, jaundice (yellowing of the skin or eyes), or clay-coloured stools.
Hypoglycaemia (low blood sugar): Individuals with type 2 diabetes, especially those taking medications such as sulfonylureas or insulin, may experience an increased risk of low blood sugar. This is both a common and potentially serious side effect. Talk to your healthcare provider about recognizing and managing low blood sugar. Symptoms may include dizziness, blurred vision, anxiety, irritability, sweating, slurred speech, hunger, confusion, drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery. Be sure to check your blood sugar before and during treatment with Wegovy.
Kidney problems: In individuals with existing kidney issues, diarrhoea, nausea, and vomiting can lead to dehydration, worsening kidney function. It is important to stay hydrated to minimize this risk.
Serious allergic reactions: Discontinue use of Wegovy and seek immediate medical attention if you experience symptoms of a serious allergic reaction, such as swelling of the face, lips, tongue, or throat, difficulty breathing or swallowing, severe rash or itching, fainting, dizziness, or rapid heartbeat.
Vision changes in individuals with type 2 diabetes: Notify your healthcare provider if you experience any changes in vision while taking Wegovy.
Increased heart rate: Wegovy can cause an increased heart rate at rest. If you experience a racing or pounding heart lasting several minutes, inform your healthcare provider.
Mental health concerns (depression or thoughts of suicide): Pay close attention to any new or worsening mental health symptoms, such as changes in mood, behaviours, thoughts, or feelings. Contact your healthcare provider immediately if you experience any concerning changes.
Do not use Wegovy if you:
Have or have had a family history of medullary thyroid carcinoma (MTC), a type of thyroid cancer, or if you have a condition known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Have had a serious allergic reaction to Semaglutide or any ingredient in Wegovy.
Before using Wegovy, inform your healthcare provider if you have any of the following conditions:
A history of pancreatic or kidney problems.
Type 2 diabetes with a history of diabetic retinopathy.
A history of depression, suicidal thoughts, or mental health issues.
Are pregnant or planning to become pregnant. Wegovy may harm an unborn baby, and you should stop using it at least 2 months before trying to conceive.
Are breastfeeding or plan to breastfeed. It is unknown whether Wegovy passes into breast milk.
Always consult your healthcare provider for the most personalized and accurate advice.
